Pterostilbene treatment has been suggested to increase caspase 3 activity and expression, a critical mediator of mitochondrial apoptosis, and pterostilbene also could induce both caspase-dependent apoptosis and caspase-independent apoptosis in breast cancer cells [12], [14], [15]. Here, CASP3 is linked to breast carcinoma.